For more information or confidential assistance
800-306-3180
se habla español

Deceptive Marketing at Crux of Androgel Lawsuit

The U.S. Food and Drug Administration has yet to approve any type of testosterone replacement therapy as a treatment for age-associated low testosterone levels, otherwise known as “Low T.” Yet manufacturers of testosterone supplements have aggressively marketed products like Androgel to thousands of middle aged American men who believed they... Read more »

Risperdal Lawsuit Claims Promotion of Off-Label Use

A resident of Minnesota has filed a Risperdal lawsuit, alleging that the medication resulted in gynecomastia and other severe complications. The lawsuit, which was filed in the U.S. District Court for the District of Minnesota, names Johnson & Johnson Company and Ortho-McNeil-Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, as... Read more »

Federal Judge Orders Coordination with State Actos Lawsuits

The federal judge presiding over thousands of Actos lawsuits that are currently consolidated in a multi-district litigation (MDL) recently issued a handful of case management orders. The orders are an apparent attempt to streamline the large, complex litigation, encourage large-scale settlement, and prevent duplication of thousands of state court Actos... Read more »

Xarelto Bleed Victims Join Mass Tort in Philadelphia

xarelto pill bottle
Administrative Judge Kevin Dougherty of the Philadelphia Court of Common Pleas recently issued an order that has created a mass tort docket for Xarelto lawsuits filed against Janssen Pharmaceuticals and Bayer Healthcare Pharmaceuticals. The January 21, 2015 order affects at least 75 cases that share common allegations regarding the medication,... Read more »

New Xarelto Bleeding Lawsuit Filed in California

xarelto pill bottle
Fraudulent concealment, negligence and fraud are just some of the causes of action leveled against Xarelto manufacturers by a California plaintiff who suffered personal injuries after ingesting the drug. The product liability lawsuit is just one of dozens which claim the anticoagulant is defective and inherently dangerous due to its... Read more »

New Study Reveals Testosterone Drug Risk

Byetta pancreatic cancer patient
Recent studies have provided conflicting and controversial results regarding testosterone drug risk to patients undergoing testosterone replacement therapy. However, a new report titled “Testosterone Therapy and Risk of Myocardial Infarction: A Pharmacoepidemiologic Study” published on January 13, found statistically significant results. Researchers Mahyar Etminan, Sean C. Skeldon, Sheldon Larry Goldenberg,... Read more »